吉西他滨治疗导致的致命性肺毒性。 - Suppr

Suppr

超能文献

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

作者信息

Tempero M A, Brand R

出版信息

Cancer. 1998 May 1;82(9):1800-1. doi: 10.1002/(sici)1097-0142(19980501)82:9<1802::aid-cncr33>3.0.co;2-6.

DOI:10.1002/(sici)1097-0142(19980501)82:9<1802::aid-cncr33>3.0.co;2-6

PMID:9576306

Abstract

摘要

相似文献

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Cancer. 1998 May 1;82(9):1800-1. doi: 10.1002/(sici)1097-0142(19980501)82:9<1802::aid-cncr33>3.0.co;2-6.

[Fatal gemcitabine administration related-pulmonary toxicity].

Farm Hosp. 2012 Nov-Dec;36(6):552-3. doi: 10.7399/FH.2012.36.6.39.

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Cancer. 1997 Jul 15;80(2):286-91. doi: 10.1002/(sici)1097-0142(19970715)80:2<286::aid-cncr17>3.0.co;2-q.

Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.

Pancreas. 2009 Oct;38(7):838-40. doi: 10.1097/MPA.0b013e3181ad97cf.

Gemcitabine-associated diffuse alveolar hemorrhage.

Intensive Care Med. 2001 Sep;27(9):1554. doi: 10.1007/s001340101037.

Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.

Lung Cancer. 2001 Jan;31(1):83-5. doi: 10.1016/s0169-5002(00)00159-8.

Gemcitabine-induced severe pulmonary toxicity.

Fundam Clin Pharmacol. 2004 Feb;18(1):85-91. doi: 10.1046/j.0767-3981.2003.00206.x.

Phase II study of gemcitabine in ovarian cancer.

Ann Oncol. 1999 Jul;10(7):853-5. doi: 10.1023/a:1008364327684.

[Gemcitabine: Applications and perspectives].

Tumori. 1997 Sep-Oct;83(5):877-80.

Hemolytic-uremic syndrome caused by gemcitabine.

Ann Oncol. 1998 Dec;9(12):1355. doi: 10.1023/a:1008467914836.

引用本文的文献

Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report.

World J Clin Cases. 2023 Feb 26;11(6):1372-1378. doi: 10.12998/wjcc.v11.i6.1372.

Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.

J Cancer Res Clin Oncol. 2004 Feb;130(2):122-5. doi: 10.1007/s00432-003-0529-4. Epub 2004 Jan 27.

A report on serious pulmonary toxicity associated with gemcitabine-based therapy.

Invest New Drugs. 2002 Aug;20(3):311-5. doi: 10.1023/a:1016214032272.

Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.

Invest New Drugs. 2001;19(1):93-100. doi: 10.1023/a:1006474600525.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Cancer. 1998 May 1;82(9):1800-1. doi: 10.1002/(sici)1097-0142(19980501)82:9<1802::aid-cncr33>3.0.co;2-6.

[Fatal gemcitabine administration related-pulmonary toxicity].

Farm Hosp. 2012 Nov-Dec;36(6):552-3. doi: 10.7399/FH.2012.36.6.39.

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Cancer. 1997 Jul 15;80(2):286-91. doi: 10.1002/(sici)1097-0142(19970715)80:2<286::aid-cncr17>3.0.co;2-q.

Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.

Pancreas. 2009 Oct;38(7):838-40. doi: 10.1097/MPA.0b013e3181ad97cf.

Gemcitabine-associated diffuse alveolar hemorrhage.

Intensive Care Med. 2001 Sep;27(9):1554. doi: 10.1007/s001340101037.

Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.

Lung Cancer. 2001 Jan;31(1):83-5. doi: 10.1016/s0169-5002(00)00159-8.

Gemcitabine-induced severe pulmonary toxicity.

Fundam Clin Pharmacol. 2004 Feb;18(1):85-91. doi: 10.1046/j.0767-3981.2003.00206.x.

Phase II study of gemcitabine in ovarian cancer.

Ann Oncol. 1999 Jul;10(7):853-5. doi: 10.1023/a:1008364327684.

[Gemcitabine: Applications and perspectives].

Tumori. 1997 Sep-Oct;83(5):877-80.

Hemolytic-uremic syndrome caused by gemcitabine.

Ann Oncol. 1998 Dec;9(12):1355. doi: 10.1023/a:1008467914836.

引用本文的文献

Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report.

World J Clin Cases. 2023 Feb 26;11(6):1372-1378. doi: 10.12998/wjcc.v11.i6.1372.

Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.

J Cancer Res Clin Oncol. 2004 Feb;130(2):122-5. doi: 10.1007/s00432-003-0529-4. Epub 2004 Jan 27.

A report on serious pulmonary toxicity associated with gemcitabine-based therapy.

Invest New Drugs. 2002 Aug;20(3):311-5. doi: 10.1023/a:1016214032272.

Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.

Invest New Drugs. 2001;19(1):93-100. doi: 10.1023/a:1006474600525.